PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER [PDF]
Christopher Craver +3 more
openalex +1 more source
Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children. [PDF]
Dadkhah A +8 more
europepmc +1 more source
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]
Dhabhar B +10 more
europepmc +1 more source
Development and validation of a risk prediction model for acute chemotherapy-induced nausea and vomiting in pediatric patients with cancers. [PDF]
Yu L +8 more
europepmc +1 more source
Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]
Wang L +8 more
europepmc +1 more source
Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis. [PDF]
Chow R +11 more
europepmc +1 more source
Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]
Jin K +7 more
europepmc +1 more source
Olanzapine: An Antiemetic Option for Chemotherapy-Induced Nausea and Vomiting
Megan V. Brafford, Ashley E. Glode
openalex +2 more sources

